Molecular microencapsulation: Paclitaxel formations in aqueous medium using hydrophobized poly(L-lysine citramide imide)

Journal of Bioactive and Compatible Polymers

Volumn 15, Issue 2, 2000, Pages 99-114

  Poujol, S ^a   Pinguet, F ^a   Bressole, F ^a,c   Boustta, M ^b   Vert, M ^b  

^a CENTRE VAL D AURELLE   (France)

^b CNRS   (France)

^c UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCK COPOLYMERS; CELLS; ENCAPSULATION; HYDROPHOBICITY; MICELLES; POLYELECTROLYTES; SOLUBILITY; SOLUTIONS; TOXICITY;

ANTITUMORAL ACTIVITY; LIPOPHILIC MICRODOMAINS; MOLECULAR MICROENCAPSULATION; OVARIAN CARCINOMA; PACLITAXEL FORMATION; PHYSICAL ENTRAPMENT; POLYLYSINE CITRAMIDE IMIDE;

POLYIMIDES;

CREMOPHOR; DRUG ADDITIVE; LYSINE DERIVATIVE; PACLITAXEL; POLY(LYSINE CITRAMIDE IMIDE); UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CANCER CELL DESTRUCTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG FORMULATION; DRUG SOLUBILITY; HUMAN; HUMAN CELL; HYDROPHOBICITY; MICROENCAPSULATION; OVARY CARCINOMA;

EID: 0034034918     PISSN: 08839115     EISSN: None     Source Type: Journal    
DOI: 10.1106/Y060-8LFN-PAJT-KJAB     Document Type: Article

References (44)

1. Crescenzi V., Adv. Polym. Sci., 5, 358, (1968).
2. Dubin P.L., and Straus U.P., J. Phys. Chem., 64, 902 (1970).
3. Villiers C., and Braud C., Nouv. J. Chim., 2, 33, (1978).
4. Vert M., Proceedings of the 28th IUPAC Macromolecular Symposium Macro 82 Amherst, Amherst Mass., USA, 1982, p. 377.
5. Braud C, Vert M., in "Polymers as Biomaterials," S.W. Shalaby, A. Hoffman, B.D. Ratner and T.A. Horbet Eds., Plenum Publ. Co., 1984, p. 17.
6. Vert M., in "Polyvalent Polymeric Drug Carriers," CRC Crit. Rev. Ther., Drug Carrier Syst., 2, 91, (1986).
7. Yokoyama M., Kwon G.S., Ikano T., Sakurai Y., Seto T. and Kataoka K., Bioconjug. Chem., 3, 295, (1992).
8. Huguet J., Vert M., J. Control. Rel., 1, 217, (1985).
9. Braud C., Vert M., Trends in Polymer Science, 3, 57, (1993).
10. Gautier S., Boustta M., Vert M., J. Bioact. Comp. Pol., 12, 77, (1997).
11. Vert M. in "Polymers in Controlled Drug Delivery," L. Illum and S.S. Davis Eds., Wright, Bristol, 1987, p. 117.
12. Illum L., Huguet J., Vert M., Davis S.S., J. Control. Rel., 3, 77, (1986).
13. Abdellaoui K., Boustta M., Mordjani H., Manfait M., Vert M., Europ. J. Pharm. Sci., 6, 61, (1998).
14. Abdellaoui K., Boustta M., Mordjani H., Manfait M., Vert M., in "Advanced Biomaterials in Biomedical Engineering and Drug Delivery Systems," N. Ogata, S.W. Kim, J. Feijen, and T. Okano Eds., Springer, Tokyo, (1996), p. 57.
15. Schiff P.B., Fant J., and Horwitz S.B., Nature, 277, 665, (1979).
16. Schiff, P.B., and Horwitz S.B., Proc. Natl. Acad. Sci. USA, 77, 1561, (1980).
17. Rowinsky E.K., Cazenave L.A., Donehower R.C., J. Natl. Cancer Inst., 82, 1247, (1990).
18. Lorenz W., Riemann H.J., Schmal A., Agents Action, 7, 63, (1977).
19. Rowinsky E.K., Onetto N., Canetta R.M., Arbuck S.G., Semin. Oncol., 6, 646, (1992).
20. Weiss, R.B., Donehower P.H., Wiernik P.H., Ohnuma T., Gralla R.J., Trump D.L., Baker J.R., Van Echo D.A., Von Hoff D.D., Leyland-Jones B., J. Clin. Oncol., 8, 1263, (1990).
21. Waugh W.N., Trissel L.A., Stella V.J., Am. J. Hosp. Pharm., 48, 1520, (1991).
22. Rowinsky E.K., McGuire W.P., Guarnieri T., Fisherman J.S., Christian M.C., Donehower R.C., J. Clin. Oncol., 9, 1704, (1991).
23. Runowicz C.D., Wiernik P.H., Einzig A.I., Goldberg G.L., Horwitz S.B., Cancer, 71, 1591, (1993).
24. Deutsh H., Glinski J., Hernandez M., Haugwitz R., Narayanan V., Suffness M., Zalkow L., J. Med. Chem., 32, 788, (1989).
25. Vyas D.M., Wong H., Crosswell A.R., Casazza, A.M., Knipe J.O., Mamber S.W., Doyle T.W., Bioorg. Med. Chem. Lett., 1357, (1993).
26. Ueda Y., Mikkilineni A.B., Knipe J.O., Rose W.C., Casazza A.M., Vyas D.M., Bioorg. Med. Chem. Lett., 3, 1761, (1993).
27. Bissery M., Guenard D., Gueritte-Voegelein F., Lavelle F., Cancer Res., 51, 4845, (1991).
28. Suffness M., Annu. Rep. Med. Chem., 28, 305, (1993).
29. Adams J.D., Flora K.P., Goldspiel B.R., Wilson J.W., Arbuck S.G., Finley R., J. Natl. Cancer Inst. Monogr., 15, 141, (1993).
30. Rose W.C., Anticancer Drugs, 3, 311, (1992).
31. Tarr B.D., Sambandan T.G., Yalkowsky S.H., 4, 162, (1987).
32. Alkan-Onyuksel H., Ramakrishnan S., Chai H.B., Pezzuto J., Pharm. Res., 11, 206, (1994).
33. Sharma U.S., Balasubramanian S.V., Straubinger R.M., J. Pharm. Sciences, 84, 1223, (1995).
34. Greenwald R.B., Gilbert C.W., Pendri A., Conover C.D., Xia J., Martinez A., J. Med. Chem., 39, 424, (1996).
35. Pesenti E., Fanzetti C., Biasoli G., Ciomei M., Pastori W., Marsiglio A., Proc. Am. Assoc. Cancer Res., 36, 307, (1995).
36. Rafaeloff R., Husain S.R., Rahman A., Proc. Ann. Meet. Am. Assoc. Cancer Res., 33: A2883, (1992).
37. Riondel J., Jacrot M., Fessi H., Puisieux F., Poiter P., In Vivo, 6, 23, (1992).
38. Bartolli M.H., Boitard M., Fessi H., Beriel H., Devissguet J.H., Picot F., Puisieux F., J. Microencapsulation, 7, 191, (1990).
39. Straubinger R.M., Sharma A., Murray M., Mayhew E., J. Natl. Cancer Inst. Monogr., 15, 69, (1993).
40. Glantz M.J., Choy H., Kearns C.M., Mills P.C., Wahlberg L.U., Zuhowski E.G., Calabresi P., Egorin M.J., J. Natl. Cancer Inst., 87, 1077, (1995).
41. Alley M.C., Scudiero D.A., Monks A., Cancer Res., 48, 589, (1988).
42. Colangelo D., Guo H.Y., Connors K.M., Kubota T., Sivestro L., Hoffmann R.M., Anticancer Res., 12, 1373, (1992).
43. Heo D.S., Park J.G., Hata K., Day R., Heberman R.B., Whiteside T.L., Cancer Res., 30, 3681, (1990).
44. Bodmaier R. and Chen H., J. Control. Rel., 12, 223, (1990).